Cancer is becoming an increasingly important health problem in the low-and middle-income countries in the Asia Pacific region, as well as in high-income countries because of ageing populations and changes in lifestyle associated with economic development and epidemiologic transition. This paper reviews the cancer burden and control in the Asia Pacific region (limited to East Asia, South Eastern Asia and Pacific Islands countries, territories and other areas), with relevant information primarily extracted from the GLOBOCAN 2008, Cancer Incidence in Five Continents series and WHO websites. Most low-and middle-income countries have a cancer control strategy and/or an action plan; however, coverage of cancer registration is still very low and does not meet the international standard in terms of quality. Therefore, only limited data were available for the recent global estimation of cancer burden. Large variations, in both cancer incidence and mortality, were observed in the populations in the different sub-regions of Asia. The most common cancer in males is lung cancer in the Eastern and South Eastern sub-regions, while prostate cancer comes close to lung cancer in the Pacific Island countries. In females, breast cancer is the most common in all three regions. The predominance of lung, stomach, colorectal, prostate, breast and cervical cancers makes cancer control more amenable in the Asia Pacific region. Up-to-date statistics on cancer occurrence and outcome are essential for the planning and evaluation of cancer control programmes. Priority can be given to population-based cancer registration, risk reduction, especially tobacco control, and primary health care based enhancement of health care systems to diagnose and manage cancer specifically in low-and middle-income countries.
INTRODUCTION
Non-communicable diseases (NCDs), which include cancer, are currently the leading global cause of deaths worldwide. A total of 57 million deaths occurred in the world in 2008, of which 36 million (63%) were due to NCDs. Nearly one-third of the deaths (.12 million) were in the Asia Pacific region, which is undergoing a rapid epidemiological transition (1) . The global leading causes of NCD deaths in 2008 were cardiovascular diseases (17 million deaths, or 48% of NCD deaths); cancer (7.6 million, or 21% of NCD deaths) and respiratory diseases, which include asthma and chronic obstructive pulmonary disease (4.2 million). Diabetes caused an additional 1.3 million deaths (1) .
Among NCDs, cancer is a unique disease entity with available morbidity information from cancer registrations. The recent global estimates of cancer incidence and mortality from 27 cancers in 2008 were published in 2010 for 184 countries, territories and other areas (2, 3) .
Until the 1980s, a few population-based cancer registries (PBCRs) provided data on cancer morbidity from China, Japan, the Philippines, Singapore and Thailand from Eastern and South Eastern Asian regions. For the Pacific region, no information was available except in Fiji (4) .
During the last two decades, cancer has become a more important health problem in the Asia Pacific region. Owing to the increasing cancer risk, only relatively high-income countries (HICs) such as Japan (5), Republic of Korea (6) and Singapore (7) , led to the development and implementation of national cancer control programmes. Further to the WHO publication on National cancer control programme (8) and the World Health Assembly resolution in 2005 (9) , several low-and middle-income countries (LMICs) also started to develop and establish their national cancer control programmes including PBCR.
There is a recent global mandate given through the Political Declaration of the United Nations General Assembly during the High Level Meeting held in September 2011, to move towards targets and indicators. In order to achieve these, it is important to assess the current situation and mechanisms for measurement.
This paper reviews the cancer burden, prevalence of main modifiable risk factors and status of cancer control programmes in countries, territories and other areas in the Asia Pacific region which is projected to have the greatest total number of NCD deaths in 2020 (10) .
DATA SOURCES AND METHOD
Countries in the two sub-regions in Asia (East, South East) and Pacific Islands Countries (Micronesia, Melanesia and Polynesia) were included in this paper on the basis of the geographical grouping followed in GLOBOCAN 2008 (http:// GLOBOCAN.iarc.fr/). The GLOBOCAN 2008 estimates were based on the most recent cancer data available in the International Agency for Research on Cancer database and the information available online (3) . Table 1 presents the data sources and methods used in the GLOBOCAN estimates by country and also provides the available data on incidence and mortality by country. Most LMICs do not have data on nationwide incidence and mortality.
The current burden of cancer in the Asia Pacific regions shows the cancer estimates and crude and adjusted rates that were taken from GLOBOCAN 2008 (published in 2010). Incidence, prevalence and mortality data sets were likewise extracted. The GLOBOCAN estimates and methods for country estimates were tabulated by countries and sub-regions.
Data on the prevalence of risk factors were extracted from the WHO Global Status Report on NCD published in 2010 (1) .
The existence of an operational policy/strategy/action plan for cancer in the country responses to the WHO 2010 NCD Country Capacity Survey was extracted from the WHO Global Health Observatory Data Repository (http://apps.who. int/ghodata/). Data on cancer registration and cancer control for the countries, territories and other areas in the Asia Pacific region were then extracted from the Cancer Incidence in Five Continents Volume IX (CI5) (11) .
RESULTS

CANCER BURDEN BASED ON GLOBOCAN ESTIMATES
Data on incidence, prevalence and mortality estimates were available in 25 countries, territories and other areas of the three sub-regions (Eastern, South Eastern and Pacific Islands) ( Table 2 ). Cancer risk varies substantially from one country to another in the sub-regions. Marked differences were also seen among men and women. Men in Republic of Korea (309.4) and women in French Polynesia (256.8) had the highest age-standardized incidence rates. Agestandardized death rates also show similar variation among countries, Mongolian men and women having the highest rates. But even with high incidence rates, HICs, such as Republic of Korea and Singapore, have relatively lower mortality rates, which is a reflection of the quality of their health care services. Countries with huge populations have very large numbers of 5 year prevalent cases. However, even smaller countries have a sizeable number of prevalent cases. Figure 1 shows 10 leading cancers by sex of each subregion. The most common cancer site in males is the lungs in the Eastern and Southeastern parts, while prostate cancer and oral cancer come close with lung cancer in the Pacific Island countries. In females, breast cancer is the leading cancer in all the three sub-regions.
Figures 2 and 3 show incidence and mortality rates of the most common cancer sites for selected countries, territories and other areas in the Asia Pacific that provided their actual data. In men, lung cancer rates were more or less similar across the sub-region except the relatively low rates in Fiji, Papua New Guinea (PNG) and Vanuatu. Countries in Eastern Asia showed high rates of stomach and liver cancers. Colorectal cancer and prostate cancer rates were higher in HICs than in LMICs.
In women, there was a 7-fold difference in breast cancer incidence rates, but it was 2.5-fold in mortality rates. Lung cancer risks were relatively similar across the sub-regions. Countries in Eastern Asia showed higher rates of stomach cancer than in Pacific Islands. Colorectal and breast cancer rates were higher in HICs than in LMICs.
PREVALENCE OF MAIN PREVENTABLE RISK FACTORS
The prevalence of major preventable risk factors and the latest year of national data of each factor, except alcohol, as published in the WHO global status report on NCD 2010, are presented in Table 3 (countries with no information were not included although cancer burden was estimated). The South Eastern Asia Brunei Darussalam Local incidence data and national mortality data: incidence was estimated from national mortality by modelling, using incidence mortality ratios derived from recorded data in local cancer registries in neighbouring countries
Local incidence data and national mortality data: incidence was estimated from national mortality by modelling, using incidence mortality ratios derived from recorded data in local cancer registries in neighbouring countries Cambodia Frequency data: age-/sex-specific incidence rates for all cancers were partitioned using data on relative frequency of different cancers (by age and sex) obtained from local source
No data: the number of cancer deaths was estimated from incidence estimates and site-specific survival, provided by neighbouring countries Indonesia The number of cancer deaths in 2008 was estimated from incidence estimates (see above) and site-specific survival, estimated by the GDP method
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Jpn J Clin Oncol 2012;42(10) 869 No data: the number of cancer deaths was estimated from incidence estimates and site-specific survival, estimated by the GDP method Papua New Guinea Frequency data: age-/sex-specific incidence rates for all cancers were partitioned using data on relative frequency of different cancers (by age and sex)
No data: the number of cancer deaths was estimated from incidence estimates and site-specific survival, estimated by the GDP method Information on smoking prevalence in some countries was not up to date and there were no national data in the DPRK, Brunei, and Solomon Islands.
Koreans in the Republic of Korea were reported to consume the highest amount of pure alcohol per capita (14.8 l) as against Indonesians, who were reported to consume the lowest amount (0.56 l). More than half of the Japanese, Malaysian and Samoan (women only) populations were reported to have insufficient physical exercise. Half the countries had no national data on physical activity. Prevalence of overweight and obesity among Pacific Islanders are 4 -5 times higher than those of Asians.
CANCER CONTROL STRATEGY AND PBCR Table 4 shows the status of cancer control policy/programme, inclusion of CI5 series (% coverage overall) and PBCR. Most countries in the Asia Pacific listed in Table 3 Leste, Solomon Islands and Samoa). The latest Cancer Incidence in Five Continents Volume IX publication included data from the central cancer registry of the Republic of Korea, Singapore and French Polynesia and PBCRs of China, Japan, the Philippines, Thailand and Vietnam. The coverage of PBCR for these countries varies from 1 to 20%. Although Mongolia had a long history of nationwide cancer registration, quality indicators of cancer cases were not fully collated for the evaluation of the cancer registration (12) . Since the National Registry of Diseases Act of Singapore was enacted in December 2007, the Singapore National Registry of Disease has been managing registries for five areas of medical care: cancer, renal disorders, stroke, acute myocardial infarction and donor care (kidney and liver) (13) . In Japan, the Cancer Control Act was enacted in 2006 and there were expectations on the standardization and improvement of all the cancer registries in 35 prefectures and one city (Hiroshima) (14) . Brunei established its national cancer registry in 2000 (15) , while the Ministry of Health in Malaysia established its National Cancer Patient Registry in 2009, which covers 75% of cancer cases (16) .
DISCUSSION
More than 70% of all cancer deaths occur in LMICs and the number of deaths has been projected to rise continuously to (2) . Cancer burden will rise more rapidly with ageing populations and changes in lifestyles associated with economic development. According to the GLOBOCAN 2008 estimates, the Asia Pacific region has less than one-third of the world population (Eastern Asia: 23.2%, South-Eastern Asia: 8.5% and Pacific Islands countries: 0.1%); however, a relatively higher proportion of cancer cases (4582 thousand, 36.2% of the global estimate: 12.6 million) and deaths (2996.5 thousand, 39.6% of the global estimate: 7.6 million) occur in these three subregions. The number of 5 year prevalent cases per population of 100 000 was 8512.6 thousand, which is 30% of the global prevalent cases. The proportion of prevalent cancer cases is a result of low survival rates. Cancer prevalence is expected to increase if there is an improved opportunity for diagnosis and treatment/management that will result in longer survival.
The economic burden of cancer will also rise as a consequence.
Although the GLBOCAN estimates provide contemporary estimates at national level for countries, data sources of many LMICs were hospital records, and the estimates of neighbouring countries were applied for estimation for the countries with no available data. Some caution may be exercised when comparing these estimates with those published earlier, because the sources of data of these estimates are not consistent and continuously improving in quality and coverage for some countries. In addition, the estimates for those countries that did not provide both mortality and incidence information are not truly comparable with those of the neighbouring countries, because information from neighbouring areas was used in the modelling (2) . Despite these constraints, the figures of overall cancer magnitude are comparable across the sub-regions. 
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Asia Pacific region, cancer burden, cancer control, cancer registration A large proportion of cancers including those of lung, stomach, oesophagus, colorectum, breast and cervical cancers are preventable. These cancers share modifiable risk factors such as tobacco use, unhealthy diet, lack of physical activity and alcohol abuse, overweight and obesity.
Tobacco is the most widely used harmful product and the main avoidable cause of cancer. One-third of male cancers and .70% of lung cancer are attributable to tobacco smoking (1, 17) . A framework for guidelines and protocols to reduce tobacco consumption and tobacco supply through evidence-based interventions was set by the WHO Framework Convention on Tobacco Control (18) . Despite many cost-effective interventions including increase in tobacco tax and prices of tobacco products, ,10% of the world's population in 2008 was fully covered by the tobacco control policies including smoke-free environments, cessation programmes, health warnings, advertising bans and taxation (19) . A stronger national initiative on tobacco control would be helpful for cancer control too.
In relation to harmful use of alcohol, effective strategies for prevention of cancers of oral cavity, pharynx, larynx, oesophagus, liver, colorectum and female breast should target both the level and patterns of alcohol consumption (1, 20) . In 2010, WHO endorsed the WHO global strategy to reduce harmful use of alcohol, which recommends 10 target areas for action in countries to reduce alcohol abuse: leadership awareness and commitment; participation in health services through counselling and treatment; community involvement in identifying needs and solutions; policies controlling drunk-driving and countermeasure; reducing the availability of alcohol; regulating the marketing of alcohol beverages; pricing policies; reducing the negative consequences of drinking and alcohol intoxication; reducing the public health impact of illicit alcohol and informally produced alcohol, and monitoring and surveillance (21) .
Unhealthy diet increase the risk of some cancers especially nasopharyngeal cancer associated with intake of salted fish and stomach cancer with limited evidence (20) . Lifestyle interventions addressing diet (salt reduction) are considered cost-effective for prevention of these cancers. In addition, healthy diet and physical activity prevent overweight and obesity as well as colorectal and breast cancers. Besides these major modifiable behavioural risk factors, infection is also an important risk factor for cancer in LMICs, as well as in some HICs in Eastern Asia. Up to one-quarter of cancer cases and deaths were attributable to infection with Helicobacter pylori, hepatitis B virus, hepatitis C virus and human papilloma virus in the Republic of Korea (22) . Thus cancer-specific strategies should include specific interventions aimed at avoidance or control of cancer-associated infections.
Monitoring these risk factors, through national NCD surveillance, is important in the cancer control programme, especially in cancer prevention. The WHO STEPS (STEPwise approach to chronic disease risk factor surveillance; http:// www.who.int/chp/steps/riskfactor/en/index.html) is also a good example of an integrated and phased-approach for risk factor (23) .
Substantial work is needed to improve PBCR, including capacity building and civil registration systems. Countries should put more emphasis on and commitment to an effective and sustainable surveillance system.
A well-conceived and well-managed national cancercontrol programme lowers cancer mortality and improves the life of cancer patients, no matter what resource constraints a country faces. In 2002, WHO published the national cancercontrol programme policies and managerial guidelines (8) and for the first time in the history of WHO, an opportunity to reinforce comprehensive cancer policies and strategies among its Member States presented itself in 2005.
The global strategy for the prevention and control of NCDs, which includes cancer, has three key components: surveillance, prevention and health care. Surveillance aims to analyse the social, economic, behavioural and political determinants of NCDs in order to evolve policy, legislative and financial measures (24) . Furthermore, cancer surveillance and monitoring through PBCR are essential for implementation of evidence-based cancer control programmes.
Since WHO adopted a cancer prevention and control resolution in 2005 (8), many LMICs have developed an operational policy, strategy or action plan for cancer and indicated the existence of a cancer control policy/strategy/plan in the WHO 2010 NCD Country Capacity Survey. But owing to limited resources and capacity, many low-income countries have not yet established a PBCR. In addition, legislative support is scarce, which is also very critical to the implementation and the operation of cancer registries and ensuring privacy.
After enacting the Cancer Control Act in countries such as the Republic of Korea in 2006 (initially in 2003 and revised in 2006) (25) and Japan (14) , countries were able to collate all the information on cancer patients obtained from hospitals. In order to support cancer registries in Asia, the establishment of a network was discussed in 2008 (26) ; however, adequate/sufficient funding and a governing body have not been negotiated and determined yet.
By having the United Nations High Level Meeting and agreement on a Political Declaration on NCDs, the matter of addressing NCDs has globally been set in motion in a tremendous manner and has seen significant progress in moving cancer onto the global health agenda (27) . This declaration has given a global mandate to prioritize NCD prevention and control. The control of cancer is one of the top priorities and we can benefit from the integrated approach to NCD risk factors, such as tobacco abuse, alcohol abuse, unhealthy diet and physical inactivity, which are risk factors for cancer as well.
Health system strengthening, especially primary health care, is needed for surveillance of suspected cancer cases and referral for further investigations and management. Well-functioning primary care systems are needed to ensure continuous and palliative care for cancer patients. All these efforts can be effective only through a good surveillance framework, which captures the population prevalence of risk factors, disease incidence and mortality, and health system performance (28) . LMICs should invest more in NCD surveillance systems and disease registries, such as cancer registries, as a priority to tackle the emerging problem of cancer and other NCDs.
